Here's the data on a potential telehealth merger.
This analysis is part of our series on 2024 M&A predictions. See all 10 matchups here.
Hims & Hers is a rare SPAC that has not cratered in the public markets.
Ro, a telehealth platform which remains private, was last valued at $7B in February 2022. However, this valuation is likely somewhat inflated given it came towards the end of the fundraising boom.
Why should Hims and Ro merge?
- Would create one of the largest telehealth platforms with diverse health services.
- Combines Hims’s wellness products with Ro’s diagnostic and treatment capabilities.
- Forms a more formidable player in the digital health sector.
Find our next M&A prediction in this series — Shopify acquires Stripe — here.
If you aren’t already a client, sign up for a free trial to learn more about our platform.